Publication dates

All regions

Colorectal Cancer Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, breast cancer, more »


 
1-20 of about 8 700 reports for Colorectal Cancer

Colorectal Cancer Drug Pipeline Update 2014

Colorectal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... And the accumulated number of ceased drugs over the last years amount to another 182 drugs. colorectal cancer drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs ...

Colorectal Cancer Drug Pathway Analyzer 2014

Colorectal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... To your pipeline specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any colorectal cancer drug ...

 Metastatic Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Metastatic Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of metastatic colorectal cancer key products to exploit opportunities for generic drug development opportunities. - Identify ...

 Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Colorectal Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of colorectal cancer key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

... Depletion and recovery technology for serum or plasma and other biological fluids. The company offers products for the treatment of colorectal cancer and prostate cancer. It holds for vascular permeability ...

4SC AG (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

4SC AG (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

... Trials. Resminostat, is being developed for the for various oncology indications including colorectal cancer, lymph node cancer (hodgkin's lymphoma) and liver cancer (hcc). Vidofludimus is indicated ...

Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis, 2014 Update

Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Feb 26, 2014: quest diagnostics expands hereditary cancer screening offering with lynch syndrome blood and biopsy testing for colorectal cancer 43feb 24, 2014: quest diagnostics to present ...

Sienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update

Sienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Cancer - product status 15telomerase test - bladder cancer - product description 15telomerase test - colorectal cancer - product status 16telomerase test - colorectal cancer - product ...

Pathology Industry: Colorectal Cancer – Pipeline Review, H1 2012

Pathology Industry: Colorectal Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of colorectal cancer- the report reviews key pipeline products under drug profile section which includes, product description, moa and r ...

Oncolytics Biotech Inc. (ONC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oncolytics Biotech Inc. (ONC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

... Of clinical testing in head and neck cancers. Reolysin has undergone various other clinical trials to determine its use in other types of cancer, such as for squamous cell carcinoma, metastatic colorectal ...

About 2 100 reports for Colorectal Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • Colorectal Cancer
  • December 2012
    25 pages
  • Colorectal Canc...  

    Cancer  

  • Canada  

View report >

4 Companies for Colorectal Cancer

Read our Company Profiles

Johnson and Johnson

United States

Eli Lilly and Co.

United States

Lilly and Co.

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.